News & Updates

Stay Tuned, Stay Ahead

Welcome to the News and Updates section of Kare PMS, the leading Integrated Pharmacy Management Software. Here, we keep you informed about the latest developments, innovations, and essential updates in the world of pharmacy management. Our commitment is to empower your pharmacy business with cutting-edge solutions, efficient tools, and compliance support.

Stay Tuned for Latest Pharmacy News & Updates

Latest News, Updates, Podcast & Even More

At Kare PMS, we are committed to continuous improvement and providing you with the best pharmacy management software in the market. Be sure to check this page regularly for upcoming events, software updates, and industry news to stay ahead of the competition.

FDA - Latest Updates

FDA – Latest Update

FDA Drug Topics: An Update on Transmucosal Buprenorphine and Dental Caries - December 10, 2024 November 20, 2024
FDA Drug Topics: An Update on Transmucosal Buprenorphine and Dental Caries - December 10, 2024 Anonymous (not verified) Wed, 11/20/2024 - 15:21 Detailed Description On Tuesday, December 10, 2024, CDER's Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Update on Transmucosal Buprenorphine and Dental Caries. In […]
Anonymous
Fabalish Inc. Recalls “Kickin’ Carrot Falafel Bites” Because of Possible Health Risk November 20, 2024
Fabalish Inc. Recalls “Kickin’ Carrot Falafel Bites” Because of Possible Health Risk Anonymous (not verified) Wed, 11/20/2024 - 14:01 Recall Type Company Announcement Brand Name(s) Fabalish Recall Reason Food & Beverage Safety,Potential Foodborne Illness,E. coli Company or Government Agency Name Fabalish Inc. Short Title Date 11-18-2024 Fabalish Body Fabalish Inc, Carlstadt, NJ is recalling Kickin’ […]
Anonymous
Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole November 20, 2024
Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole Anonymous (not verified) Wed, 11/20/2024 - 12:25 Recall Type Company Announcement Brand Name(s) Umary Recall Reason Device & Drug Safety,Unapproved Drug Company or Government Agency Name MXBBB Short Title Date 11-19-2024 UMARY Body MXBBB is voluntarily recalling 1 […]
Anonymous
FDA approves updated drug labeling for fludarabine phosphate under Project Renewal November 20, 2024
FDA approves updated drug labeling for fludarabine phosphate under Project Renewal Anonymous (not verified) Wed, 11/20/2024 - 08:47 Detailed Description On November 19, 2024, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for certain older […]
Anonymous
Babcock Dairy Expands Recall on Orange Custard Chocolate Chip and Chocolate Peanut Butter Due to Undeclared Egg November 20, 2024
Babcock Dairy Expands Recall on Orange Custard Chocolate Chip and Chocolate Peanut Butter Due to Undeclared Egg Anonymous (not verified) Tue, 11/19/2024 - 19:44 Recall Type Company Announcement Brand Name(s) Babcock Dairy Recall Reason Food & Beverage Safety,Potential or Undeclared Allergen,Eggs Company or Government Agency Name Babcock Dairy Short Title Date 11-19-2024 Babcock Dairy Body […]
Anonymous

NABP - Latest Updates

NABP – Latest Updates

Initial Results Demonstrate Moderately Strong Relationship Between NAPLEX Advantage and Future NAPLEX Performance November 20, 2024
In January 2024, NABP launched the NAPLEX Advantage™ assessment tool which provides colleges of pharmacy and students with a testing experience that mimics the North American Pharmacist Licensure Examination® (NAPLEX®). Like the NAPLEX, the NAPLEX Advantage is administered in a secure and proctored environment. Comprised of 100 questions that were previously used on the NAPLEX, […]
Emily Eddy
Transformative Technologies Present Opportunities for Pharmacy Practice and Regulation November 13, 2024
From new uses and strategies related to central fill to improvements in telepharmacy, transformative technologies continue to empower pharmacists to deliver more efficient and effective services. So, what new tools are in the adoption phase today? What pharmacy practice innovations are on the next horizon? What legislative and regulatory efforts are currently in progress that […]
Emily Eddy
Driving Provider Value for Specialty Pharmacies November 6, 2024
Launched in 2019, NABP’s Specialty Pharmacy Accreditation was created to accredit pharmacies providing advanced levels of pharmacy services and disease management tools for patients taking medications that require special handling, storage, and dispensing requirements. In addition, this accreditation is ideal for pharmacies that provide pharmacist coordinated patient education and training, such as promoting adherence and […]
Emily Eddy
WellBeing First Challenge: Health Care Workers’ Rights October 30, 2024
As we close out American Pharmacists Month, we highlight the importance of supporting mental health and well-being in the pharmacy. The Dr. Lorna Breen Heroes’ Foundation, through its WellBeing First Challenge is working to reduce burnout of health care professionals and safeguard their well-being and job satisfaction. The organization envisions a world where seeking mental […]
Emily Eddy
FDA’s DSCSA Exemption for Connected Trading Partners October 23, 2024
Full enforcement of the Drug Supply Chain Security Act (DSCSA) was set to begin on November 27, 2024, at the conclusion of the one-year FDA Stabilization Period. On October 10, 2024, U.S. Food & Drug Administration (FDA) issued an exemption notice for certain DSCSA requirements. We support this decision. FDA took the right approach balancing the advancement […]
Emily Eddy

Latest Updates - Pharmacy Times

Latest Pharmacy Times Updates

Increase of Vitamin D Supplements Could Lower Blood Pressure Among Older Individuals With Obesity November 20, 2024
Vitamin D and calcium decreased systolic and diastolic blood pressure among older individuals with obesity.
Investigators Present New Data About HPV Vaccine, Supporting Its Use November 20, 2024
Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.
Nasal Swab Test Can Predict COVID-19 Severity Through Autoantibody Analysis November 20, 2024
Severity of a COVID-19 illness could be determined by examining autoantibodies in the nasal cavity, allowing more personalized treatment protocols.
Study Finds Nearly 75% of Adults 25 and Older Have Overweight or Obesity November 20, 2024
If patterns and trends were to continue, the authors predict that nationwide overweight and obesity prevalence in adults will surpass 80% by 2050.
Early Asthma Onset Associated With Memory and Executive Function Difficulties in Children November 20, 2024
Inflammation associated with asthma in children could perturb neurodevelopment.

Latest Updates - PharTech

Latest PharmTech Updates

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity November 20, 2024
SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.
Challenges and Triumphs in Next-Generation Biotherapeutic Development November 20, 2024
Webinar Date/Time: Fri, Dec 13, 2024 11:00 AM EST
Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing November 19, 2024
Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.
PTC Therapeutics Gains FDA Approval for AADC Deficiency Gene Therapy November 19, 2024
FDA's approval of eladocagene exuparvovec-tneq (Kebilidi) makes that product the first FDA-approved gene therapy for treating AADC deficiency.
Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment November 16, 2024
Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.
EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease November 16, 2024
CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.
Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges November 15, 2024
Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.
Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics November 15, 2024
Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

News & Updates

Stay Tuned, Stay Ahead

Stay Tuned for Latest Pharmacy News & Updates

Latest News, Updates, Podcast & Even More

FDA - Latest Updates

FDA – Latest Update

NABP - Latest Updates

NABP – Latest Updates

Latest Updates - Pharmacy Times

Latest Pharmacy Times Updates

Latest Updates - PharTech

Latest PharmTech Updates

FOLLOW, SHARE, LIKE & SUBSCRIBE US ON SOCIAL MEDIA FOR LATEST UPDATES

Not Sure Where To Start From?

Let's Talk

Meet Us

Call Us

Email Us

Let's Get In touch

like, share, follow

important links

HEALTHLINK SOLUTIONS